Director RIEDEL NORBERT G 🟢 acquired 20.0K shares (2 derivative) of Eton Pharmaceuticals, Inc. (ETON) at $15.47 Transaction Date: Jan 12, 2026 | Filing ID: 001301
Director Adams Jennifer McKie 🟢 acquired 20.0K shares (2 derivative) of Eton Pharmaceuticals, Inc. (ETON) at $15.47 Transaction Date: Jan 12, 2026 | Filing ID: 001298
Director CASAMENTO CHARLES J 🟢 acquired 20.0K shares (2 derivative) of Eton Pharmaceuticals, Inc. (ETON) at $15.47 Transaction Date: Jan 12, 2026 | Filing ID: 001296
Director MAIER PAUL V 🟢 acquired 20.0K shares (2 derivative) of Eton Pharmaceuticals, Inc. (ETON) at $15.47 Transaction Date: Jan 12, 2026 | Filing ID: 001294
Director BRYNJELSEN SEAN 🟡 adjusted position in 253.5K shares (2 derivative) of Eton Pharmaceuticals, Inc. (ETON) at $15.47 ($2.5M) Transaction Date: Jan 12, 2026 | Filing ID: 001290
Krempa David 🟡 adjusted position in 64.6K shares (2 derivative) of Eton Pharmaceuticals, Inc. (ETON) at $15.62 Transaction Date: Jan 12, 2026 | Filing ID: 001288